NSE: BIOCON | BSE: 532523

Slowing Down Stock

Download real time

328.85 12.30 (3.89%)

26.55% Gain from 52W Low

3.4M NSE+BSE Volume

NSE 15 Apr, 2025 3:31 PM (IST)

39,481.7

Market Cap

Market Leader

1.2

Beta 1Year

Very High Volatility

Signs Agreement

Biocon's arm enters a settlement and license agreement with Regeneron to market Yesafili in the US See details

Biocon Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Biocon Ltd. from all sources in a single place.

Is Biocon Ltd. worth buying?

714 Votes:

Buy 75.07%

Sell 16.39%

Hold 8.54%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >